文献速递肿瘤 PET/CT

基于¹⁸F-FDG PET/CT肿瘤代谢参数与临床特征的滤泡性淋巴瘤早期预后分层

Early prognostic stratification of follicular lymphoma through ¹⁸F-FDG PET/CT tumor metabolic parameters and clinical characteristics.
PubMed 文献 · EJNMMI Res · 2026-02-04

该研究纳入123例滤泡性淋巴瘤患者,33例(26.8%)在24个月内出现疾病进展(POD24)。研究基于基线¹⁸F-FDG PET/CT代谢参数(TLG、TMTV、Dmax、DmaxVox)及临床指标LDH构建评分系统,联合模型对POD24预测的AUC为0.759,并可将患者分为POD24发生率分别为5.7%、26.1%和57.1%的三个风险组。

要点

  • 基线TMTV>94.08 cm³与DmaxVox>77.92 cm为POD24独立影像预测因子。
  • LDH升高为POD24独立临床风险因素(OR 3.267)。
  • 联合LDH、TMTV与DmaxVox的三组分层POD24发生率分别为5.7%、26.1%、57.1%。

核心结论

  • 基线¹⁸F-FDG PET/CT的TMTV和DmaxVox及临床参数LDH是FL患者24个月内早期进展(POD24)的独立预测因子。
  • 联合影像指标与临床参数的预测模型可有效进行风险分层,联合模型对POD24预测的AUC为0.759。

研究设计与样本

  • 回顾性研究,纳入123例滤泡性淋巴瘤患者,随访24个月内评估POD24。
  • 基于基线¹⁸F-FDG PET/CT肿瘤代谢参数与临床特征构建评分系统,采用ROC曲线确定最佳截断值,并建立联合预测模型。

主要发现

  • 123例FL患者中33例(26.8%)发生POD24。
  • LDH为POD24独立风险因素[OR: 3.267 (1.055, 10.117),P = 0.040]。
  • TLG > 628.59 g [OR: 5.1430 (1.9360, 13.6580),P = 0.001]、TMTV > 94.08 cm³ [OR: 11.8530 (2.6730, 52.5640),P = 0.001]、Dmax > 37.22 cm [OR: 3.0000 (1.1880, 8.6878),P = 0.028]、DmaxVox > 77.92 cm [OR: 8.0620 (2.2830, 28.4720),P = 0.001]均为POD24风险因素。
  • TLG与TMTV显著正相关(r = 0.95),Dmax与DmaxVox显著正相关(r = 0.99)。
  • 基于LDH、TMTV和DmaxVox的三组分层POD24发生率分别为5.7%、26.1%、57.1%(P < 0.001)。

关键数值与推荐

  • TLG最佳截断值628.59 g,TMTV最佳截断值94.08 cm³,Dmax最佳截断值37.22 cm,DmaxVox最佳截断值77.92 cm。
  • 联合模型预测POD24的AUC = 0.759,决策曲线分析和校准曲线证实模型稳健。

临床怎么用

  • 对初诊FL患者,可基于基线¹⁸F-FDG PET/CT测量的TMTV、DmaxVox及临床LDH进行POD24风险分层。
  • 联合模型有助于识别高危POD24患者,可能为个体化治疗决策提供参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Follicular lymphoma (FL), as the most common indolent lymphoma, exhibits reduced survival rates in patients with early progression compared to those without early progression. We aimed to develop a scoring system integrating baseline 18F-FDG PET/CT tumor metabolic parameters with clinical and other relevant factors to personalize the prediction of disease progression within 24 months (POD24) in FL patients. RESULTS: Among 123 patients with FL, 33 (26.8%) experienced disease progression within 24 months of follow-up. Among clinical indicators, Lactate dehydrogenase (LDH) [OR: 3.267 (1.055, 10.117), P = 0.040] was an independent risk factor for POD24. Based on the receiver operating characteristic (ROC) curve, the optimal cutoff values for Total lesion glycolysis (TLG), total metabolic tumor volume (TMTV), maximum distance of spread (Dmax), and voxel-based maximum interlesion distance (DmaxVox) in POD24 patients were 628.59 g, 94.08 cm³, 37.22 cm, and 77.92 cm, respectively. Additionally, TLG > 628.59 g [OR: 5.1430 (1.9360, 13.6580), P = 0.001], TMTV > 94.08 cm³ [OR: 11.8530 (2.6730, 52.5640), P = 0.001], Dmax > 37.22 cm [OR: 3.0000 (1.1880, 8.6878), P = 0.028], and DmaxVox > 77.92 cm [OR: 8.0620 (2.2830, 28.4720), P = 0.001] were all risk factors for POD24 patients. The correlation heatmap revealed significant positive correlations between TLG and TMTV (r = 0.95) and between Dmax and DmaxVox (r = 0.99). Patients were stratified into three risk groups based on clinical LDH and imaging parameters TMTV and DmaxVox, with POD24 incidence rates of 5.7%, 26.1%, and 57.1%, respectively (P < 0.001). The constructed integrated model demonstrated the highest predictive performance for POD24 (AUC = 0.759). Decision curve analysis (DCA) and calibration curves confirmed the model's robust predictive capability. CONCLUSIONS: TMTV and DmaxVox on baseline 18F-FDG PET/CT imaging, along with the clinical parameter LDH, are independent predictors of early disease progression within 24 months (POD24) in patients with FL. A predictive model combining these imaging metrics with clinical parameters effectively stratifies patient risk.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Li SC, Xu JY, Fan X, et al. Early prognostic stratification of follicular lymphoma through ¹⁸F-FDG PET/CT tumor metabolic parameters and clinical characteristics. EJNMMI Res. 2026. PMID: 41639500. doi:10.1186/s13550-026-01384-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。